Search research articles
Contact Us
Filters
Showing results (51-60 of 162) with videos related to
Page
of 17
Sort By:
The American Journal of Cardiology
|
January 1, 1997
Putting low-density lipoproteins at center stage in atherogenesis
A D Sniderman, T Pedersen, J Kjekshus
Drugs
|
January 1, 1990
M-mode echocardiography in patients with severe congestive heart failure. A subgroup analysis in the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
S V Eriksson, J Offstad, J Kjekshus
The American Journal of Cardiology
|
January 15, 1997
Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
K N Nguyen, I Aursnes, J Kjekshus
Clinical Cardiology
|
April 1, 1994
The plasma concentration of N-terminal proatrial natriuretic factor ANF(1-98) is related to prognosis in severe heart failure
C Hall, J Kjekshus, P Eneroth, et al.
European Heart Journal
|
October 1, 1985
Timolol maleate and HDL cholesterol after myocardial infarction
T Gundersen, J Kjekshus, O Stokke, et al.
Circulation
|
November 1, 1983
Quantitative assessment of myocardial ischemia and necrosis by continuous vectorcardiography and measurement of creatine kinase release in patients
M Sederholm, P Grøttum, L Erhardt, et al.
International Journal of Cardiac Imaging
|
April 29, 1998
Left ventricular volumes assessed by different new three-dimensional echocardiographic methods and ordinary biplane technique
O Rodevand, R Bjornerheim, S Aakhus, et al.
Acta Physiologica Scandinavica
|
April 1, 1984
Cardiovascular responses to face immersion and apnea during steady state muscle exercise. A heart catheterization study on humans
L Bjertnaes, A Hauge, J Kjekshus, et al.
European Journal of Clinical Pharmacology
|
May 31, 1978
Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose
A S Westheim, C C Christensen, J Kjekshus
Current Opinion in Cardiology
|
July 1, 1996
Lipid-lowering therapy for patients with or at risk of coronary artery disease
J Kjekshus, T R Pedersen, J A Tobert
Page
of 17
Search research articles
Search
Showing results (51-60 of 162) with videos related to
Sort By:
Page
of 17
The American Journal of Cardiology
|
January 1, 1997
Putting low-density lipoproteins at center stage in atherogenesis
A D Sniderman, T Pedersen, J Kjekshus
Drugs
|
January 1, 1990
M-mode echocardiography in patients with severe congestive heart failure. A subgroup analysis in the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
S V Eriksson, J Offstad, J Kjekshus
The American Journal of Cardiology
|
January 15, 1997
Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
K N Nguyen, I Aursnes, J Kjekshus
Clinical Cardiology
|
April 1, 1994
The plasma concentration of N-terminal proatrial natriuretic factor ANF(1-98) is related to prognosis in severe heart failure
C Hall, J Kjekshus, P Eneroth, et al.
European Heart Journal
|
October 1, 1985
Timolol maleate and HDL cholesterol after myocardial infarction
T Gundersen, J Kjekshus, O Stokke, et al.
Circulation
|
November 1, 1983
Quantitative assessment of myocardial ischemia and necrosis by continuous vectorcardiography and measurement of creatine kinase release in patients
M Sederholm, P Grøttum, L Erhardt, et al.
International Journal of Cardiac Imaging
|
April 29, 1998
Left ventricular volumes assessed by different new three-dimensional echocardiographic methods and ordinary biplane technique
O Rodevand, R Bjornerheim, S Aakhus, et al.
Acta Physiologica Scandinavica
|
April 1, 1984
Cardiovascular responses to face immersion and apnea during steady state muscle exercise. A heart catheterization study on humans
L Bjertnaes, A Hauge, J Kjekshus, et al.
European Journal of Clinical Pharmacology
|
May 31, 1978
Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose
A S Westheim, C C Christensen, J Kjekshus
Current Opinion in Cardiology
|
July 1, 1996
Lipid-lowering therapy for patients with or at risk of coronary artery disease
J Kjekshus, T R Pedersen, J A Tobert
Page
of 17